Profound Medical Corp. (PRN.TO)
9.83
-0.01
(-0.10%)
CAD |
TSX |
Oct 09, 16:00
Profound Medical Net Income (Quarterly) : -13.21M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.21M |
| March 31, 2026 | -9.675M |
| December 31, 2025 | -11.40M |
| September 30, 2025 | -10.99M |
| June 30, 2025 | -21.73M |
| March 31, 2025 | -15.39M |
| December 31, 2024 | -6.917M |
| September 30, 2024 | -12.77M |
| June 30, 2024 | -9.467M |
| March 31, 2024 | -8.360M |
| December 31, 2023 | -12.13M |
| September 30, 2023 | -7.456M |
| June 30, 2023 | -9.398M |
| March 31, 2023 | -9.277M |
| December 31, 2022 | -12.93M |
| September 30, 2022 | -6.527M |
| June 30, 2022 | -7.572M |
| March 31, 2022 | -10.41M |
| December 31, 2021 | -12.81M |
| September 30, 2021 | -7.555M |
| June 30, 2021 | -8.647M |
| March 31, 2021 | -9.496M |
| December 31, 2020 | -9.773M |
| Date | Value |
|---|---|
| September 30, 2020 | -8.136M |
| June 30, 2020 | -7.348M |
| March 31, 2020 | -3.608M |
| December 31, 2019 | -5.152M |
| September 30, 2019 | -6.270M |
| June 30, 2019 | -5.844M |
| March 31, 2019 | -2.927M |
| December 31, 2018 | -4.859M |
| September 30, 2018 | -5.135M |
| June 30, 2018 | -5.831M |
| March 31, 2018 | -4.938M |
| December 31, 2017 | -4.529M |
| September 30, 2017 | -5.520M |
| June 30, 2017 | -4.658M |
| March 31, 2017 | -4.115M |
| December 31, 2016 | -4.789M |
| September 30, 2016 | -4.061M |
| June 30, 2016 | -3.641M |
| March 31, 2016 | -3.836M |
| December 31, 2015 | -2.770M |
| September 30, 2015 | -2.957M |
| June 30, 2015 | -8.699M |
| March 31, 2015 | -1.950M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| MedMira, Inc. | -0.4837M |
| MedX Health Corp. | -1.602M |
| VentriPoint Diagnostics Ltd. | -0.1998M |
| Theralase Technologies, Inc. | -1.062M |
| VVT Med, Inc. | -0.7725M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.437M |
| Total Expenses (Quarterly) | 16.64M |
| EPS Diluted (Quarterly) | -0.3633 |
| Enterprise Value | 315.29M |
| Gross Profit Margin (Quarterly) | 78.41% |
| Profit Margin (Quarterly) | -384.2% |
| Earnings Yield | -13.89% |
| Normalized Earnings Yield | -13.89 |